Anja Liepert

Dendritic Cells (DCs) Can Be Successfully Generated From Leukemic Blasts in Individual Patients With AML or MDS

Andreas Kremser, Julia Dreyig, Christine Grabrucker et al. · Journal of Immunotherapy · 2010 · 65 citations

Leukemic Blasts, Hematological Malignancy, Individual Patients +15

The Quality and Quantity of Leukemia-derived Dendritic Cells From Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome Are a Predictive Factor for the Lytic Potential of Dendritic Cells-primed Leukemia-Specific T Cells

Christine Grabrucker, Anja Liepert, Julia Dreyig et al. · Journal of Immunotherapy · 2010 · 42 citations

Cell Therapy, Immunology, Immunoediting +17

Quality of T-cells after stimulation with leukemia-derived dendritic cells (DC) from patients with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) is predictive for their leukemia cytotoxic potential

Anja Liepert, Christine Grabrucker, Andreas Kremser et al. · Cellular Immunology · 2010 · 30 citations

Hematological Malignancy, Cell Therapy, Medicine +10

CD4+ and CD8+T-cell reactions against leukemia-associated- or minor-histocompatibility-antigens in AML-patients after allogeneic SCT

Brigitte Steger, Slavoljub Milosevic, Georg Doessinger et al. · Immunobiology · 2013 · 23 citations

Hematological Malignancy, Cell Therapy, Transplantation +12

Serum Chemokine-release Profiles in AML-patients Might Contribute to Predict the Clinical Course of the Disease

Marion Merle, Dorothea Fischbacher, Anja Liepert et al. · Immunological Investigations · 2019 · 16 citations · Full text

Chemokine Biology, Immunology, Immune Regulation +18